このエントリーをはてなブックマークに追加
ID 14075
Eprint ID
14075
FullText URL
Thumnail 106_493.pdf 551 KB
Title Alternative
Studies on malignant lymphoma Part 1. Second malignant neoplasms in patients with malignant lymphoma after chemotherapy
Author
Tagawa, Shinya
Abstract
The risk of a second malignancy was analyzed in 23 patients with Hodgkin's disease (HD) and 177 with non-Hodgkin's lymphoma (NHL) who were initially treated with combination chemotherapy between 1976 and 1990. Among these patients, 3 cases of gastric cancer, 2 cases of lung cancer, 2 cases of hepatoma, one case of colon cnacer, one case of cholangiocarcinoma and one case of acute myeloblastic leukemia were subsequently observed. Median age at diagnosis of lymphoma was 64 years in patients who developed subsequent malignancies but was 9 years higher than that for the entire lymphoma group. Median interval from srart of chemotherapy to the appearance of second malignancy was 43.9 years and ranged from 1.9 years to 8.8 years. The 7-year cumulative risk of second malignancy in HD and NHL were 7.7% and 11.7%, respectively. In Hodgkin's disease, the incidence of stomach and lung cancers was significantly greater than expected incidence calculated on the basis of age-adjusted person-years. In non-Hodgkin's lymphoma, the incidence was also greater than expected for all malignancies except stomach cancer. This indicater that the incidence of solid malignancy as well as leukemia is higher in lymphoma patients after chemotherapy than in the general population.
Keywords
malignant lymphoma
chemotherapy
second primary malignancy
Note
原著
Published Date
1994
Publication Title
岡山医学会雑誌
Publication Title Alternative
Journal of Okayama Medical Association
Volume
volume106
Issue
issue5-6
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
493
End Page
503
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Official Url
https://www.jstage.jst.go.jp/article/joma1947/106/5-6/106_5-6_493/_article/-char/ja/
Related Url
http://www.okayama-u.ac.jp/user/oma/
References
1) Bonadonna G, Valagussa P and Santoro A : Alternating non-cross-resistant combination chemother-apy or MOPP in stage Ⅳ Hodgkin's disease. Ann Intern Med (1986) 104, 739-746.
2) Connors JM and Klimo P : MACOP-B chemotheraph for malignant lymphomas and related condi-tions : 1987 update and additional obsarvations. Semin Hematol (1988) 25, 41-46.
3) Longo DL, DeVita VT, Jr, Duffey PL, Wesley MN, Ihde DC, Hubbard SM, Gilliom M, Jaffe ES, Cossman J, Fisher RJ and Young RC : Superiority of ProcMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma : results of a prospective randomized trial. J Clin Oncol (1991) 9, 25-38.
4) 木村郁郎, 大熨泰亮, 中田安成, 岡  瞭, 平木俊吉, 占部康雄, 藤井昌史, 林 恭一, 佐藤方春, 片岡幹男, 西尾竜司, 寺尾誠也, 三戸敏正, 田仲俊雄 : 悪性リンパ腫治療における Vincristine, Bleomycin, Cyclophosphamide および Prednisolone 4剤併用療法 : 長期観察で得られた成績について. 臨床血液 (1980) 21, 792-800.
5) 西原龍司 : 悪性リンパ腫の化学療法に関する研究. 第2編 進展期悪性リンパ腫に対する多剤併用療法の治療効果 : 長期観察による検討. 岡山医誌 (1985) 97, 661-676.
6) 大熨泰亮 : 各種癌患者に対する治療に実際. 悪性リンパ腫. 臨床と研究 (1985) 62, 3124-3132.
7) 多田敦彦, 大熨泰亮, 林 恭一, 上岡 博, 上野邦夫, 村嶋 誠, 水田 潤, 吉田光男, 木村郁郎 : びまん性大細胞型非ホジキンリンパ腫に対する多剤併用療法の治療成績ーAdriamycin を含む多剤併用療法の有用性について. 癌と化学療法 (1987) 14, 2692-2696.
8) Ohnoshi T, Hayashi K, Ueno K, Tada A, Mizuta J, Tagawa S, Matsutomo S, Saito S, Kawashima K, Yoshino T and Kimura I : Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma : a single institutional study with a long-term follow-up. Int J Hematol (1993) 58, 93-98.
9) Tucker MA, Coleman CN, Cox RS, Varghese A and Rosenberg SA : Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med (1988) 14, 76-81.
10) Pedersen-Bjergaard J, Specht L, Larsen SO, Ersboll J, Struck J, Hansen MM, Hansen HH and Hissen NI : Risk of therapy-related leukemia and preleukemia after Hodgkin's disease. Lancet (1987) 11, 83-88.
11) Bartolucci AA Liu C, Durant JR and Grams RA : Acute myelogenous leukemia as a second malignant neoplasm following the successful of advanced Hodgkin's disease. Cancer (1983) 52, 2209-2213.
12) Leeuwen FE, Somers R, Taal BG, Heerde P, Coster B, Dozeman T, Huisman SJ and Hart AAM : Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 7, 1046-1058.
13) Coleman MP, Bell CMJ and Fraser P : Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis : A population-based cohort study. Br J Cancer (1987) 56, 349-355.
14) List AF, Doll DC and Greco FA : Lung cancer in Hodgkin's disease : Association with previous radiotherapy. J Clin Oncol (1985) 3, 215-221.
15) 須知泰山, 若狭治毅, 三方淳男, 難波紘二, 菊池昌弘, 森 茂郎, 毛利 昇, 渡辺 昌, 社本幹博, 田島和雄, 張ヶ谷健一, 桐野有爾, 高木敬三, 福永真治, 板垣哲朗, 松田幹男 : 非ホジキンりンパ腫病理組織診断の問題点. 新分類の提案. 最新医学 (1979) 34, 2049-2062.
16) Carbone PP, Kaplan HS, Husshoff K, Smither DW and Tubiana M : Report of the committee on Hodgkin's disease staging classification. Cancer Res (1971) 31, 1860-1861,
17) Kaplan EL and Meier P : Nonparametric estimation from incomplete observation. J Am Stat Assoc (1983) 78, 1-12.
18) The Research Group for Population-based Cancer Registration in Japan : Cancer incidence in Japan. 1975-cancer registry statistics. GANN Monogr Cancer Res (1981) 26, 92-116.
19) Greene MH, Young RC, Merrill JM and DeVita VT : Evidence of a treatment dose response in acute nonlymphocytic leukemia which occur after therapy of non-Hodgkin's lymphoma. Cancer Res (1983) 43, 1891-1898.
20) Pedersen-Bjergaard J, Ersboll J, Sorensen HM, Keiding N, Larsen SO, Philip P, Larsen MS, Schults H and Niseen NI : Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophoshamide for non-Hodgkin's lymphomas. Ann Intern Med (1985) 103, 195-200.
21) Zarrabi MH : Association of non-Hodgkin's lymphoma and second neoplasms. Semin Oncol (1990) 17, 120-132.
22) Takenaka T, Konda C, Sakano T, Shimoyama M, Kitahara T, Minato K and Watanabe S : Second primary malignancies in lymphoma patients. Jpn J Clin Oncol (1985) 15, 443-449.
23) 名倉英一, 川島康平 : がん治療における二次発がんー造血器腫瘍ー. 癌と化学療法 (1986) 13, 1464-1474.
24) Glicksman AS, Pajak TF, Gottlieb A, Nissen N, Stutzman L and Cooper MR : Second malignant neoplasms in patients successfully treated for Hodgkin's disease : A Cancer and Leukemia Group B study. Cancer Treat Rep (1982) 66, 1035-1044.
25) Coltman CA and Dixon DO : Second malignancies complicating Hodgkin's disease : A Southwest Oncology Group 10-year follow up. Cancer Treat Rep (1982) 66, 1023-1033.
26) Tester WJ, Kinsella TJ, Waller B, Makuch RW, Kelley PA, Glastein E and DeVita VT : Second malignant neoplasms complicating Hodgkin's disease : The National Cancer Institute experience. J Clin Oncol (1984) 2, 762-769.
27) Valagussa P, Santoro A, Fossati-Bellani F, Banfi A and Bonadonna G : Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol (1986) 4, 830-837.
28) Climino G, Papa G, Tura S, Mazza P, Ferini PLR, Bosi A, Amadori S, Coco FL, D'Arcangelo E, Giannarelli D and Mandelli F : Second primary cancer followong Hodgkin's disease : Updated results of an Italian Multicentric Study. J Clin Oncol (1991) 9, 432-437.
29) Penn I : Cancer is a complication of severe immunosuppression. Surg Gynecol & Obstet (1986) 162, 603-610.
language
日本語
Copyright Holders
Copyright© 岡山医学会
File Version
publisher
Refereed
True
Eprints Journal Name
joma